1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Medical Affairs Reputations: Cancer Pain (US) 2017

Medical Affairs Reputations: Cancer Pain (US) 2017

  • July 2017
  • ID: 5175248
  • Format: PDF
  • By Firstword Pharma


Table of Contents

Disappointing scores show that medical affairs teams need to up their game

The medical oncologists we surveyed say that medical affairs teams for cancer pain drugs turned in a lacklustre performance in the past 6 months. Their ratings on individual services barely crept into positive territory, and even though they’re contacting doctors a little too often, they’re failing to deliver the information doctors need. In other words, there’s plenty of room for improvement, and a motivated team can seize the opportunity to leap ahead of the competition.
Find out what your team gets right, and where it’s going wrong in Medical Affairs Reputations: Cancer Pain (US).

Comparing 6 major cancer pain treatments from Endo Pharmaceuticals, Insys Therapeutics, Mallinckrodt, Purdue Pharma, and Teva, this report reveals:

How doctors rate your team overall, and on 12 key medical affairs services.
Which medical affairs services are most important, and what you can do to improve them.
How, and how often doctors want to meet with your team.

That’s actionable information you can use to turn your team into one that doctors rely on.

Top Takeaways

  • Scores are so-so: Performance and satisfaction ratings for individual medical affairs services are neutral to somewhat positive. 
  • No one brand stands out: Most teams earned similar overall quality scores. Performance and satisfaction ratings are also similar. 
  • Specific improvements needed: 5 of the surveyed teams need to improve between 1 and 3 specific services. 
  • Over 40% of doctors say teams could do a better job of providing information: They identified 4 ways teams can improve, and highlighted 3 specific types of information they want more of. 
  • Teams may be over-communicating: Doctors tend to want to hear from teams less often than teams are contacting them. 
  • Time to pick up the pace: Only one team interacted with more than 65% of the surveyed doctors in the past 6 months. 

Insight into Medical Affairs Teams for These Cancer Pain Treatments

Actiq (fentanyl transmucosal; Teva) 
Exalgo (hydromorphone CR; Mallinckrodt) 
Opana (oxymorphone IR; Endo Pharmaceuticals) 
Opana ER (oxymorphone ER; Endo Pharmaceuticals) 
OxyContin (oxycodone CII; Purdue Pharma) 
Subsys (fentanyl sublingual; Insys Therapeutics) 

An Expert-designed Competitive View of Your Medical Affairs Teams
Developed with the help of medical affairs specialists, this report gives you an in-depth comparison of 6 medical affairs teams—answering important questions like: 
  • What do doctors need?
  • How, and how often are doctors using your medical affairs team? 
  • What services do they consider most important? 
  • How often should you contact them? What channels are best? 

Does your medical affairs team deliver?

How memorable are your team’s interactions with doctors?
How do doctors rank your team for performance and satisfaction in 12 key areas?
How does your team compare to the competition—in each area, and overall?

What needs improvement?

Are you delivering the services that are most important to doctors?
Where do you need to improve?
How can your team enhance its services?
Based on Expert Knowledge

We surveyed 100 US medical oncologists, chosen from the largest community of validated physicians in the world.

All respondents:
Have been practicing for between 3 and 35 years
See at least 5 patients with cancer pain in a typical month
Devote at least 50% of their time to direct patient care
Have interacted with at least one listed product’s medical affairs team in the past 6 months. 

We conducted the survey between June 1st and 7th, 2017. 

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Cholesteryl Ester Transfer Protein - Pipeline Review, H2 2019

Cholesteryl Ester Transfer Protein - Pipeline Review, H2 2019

  • $ 3500
  • December 2019

Cholesteryl Ester Transfer Protein - Pipeline Review, H2 2019SummaryAccording to the recently published report ’Cholesteryl Ester Transfer Protein - Pipeline Review, H2 2019’; Cholesteryl Ester Transfe ...

Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019

Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • December 2019

Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019" provides an overview of Hepatitis ...

Trigeminal Neuralgia (Tic Douloureux) - Pipeline Review, H2 2019

Trigeminal Neuralgia (Tic Douloureux) - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Trigeminal Neuralgia (Tic Douloureux) - Pipeline Review, H2 2019SummaryPharmaceutical and Healthcare disease pipeline guide Trigeminal Neuralgia (Tic Douloureux) - Pipeline Review, H2 2019, provides an ...

Autism - Pipeline Review, H1 2020 $ 2000 January 2020


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on